TLRY
TLRY · Small Cap · Healthcare · Drug Manufacturers - Specialty & Generic
$2.81−$0.13 (-4.27%)
Market closed · opens in 2d 2hNext open: Monday, Oct 26, 9:30 AM ETFree AI brief
Get the full brief on TLRY
Free to track. No card required. Usually ready in 10-15 minutes.
Where TLRY sits today
Price, momentum, and the numbers behind the story.
52-week range
Low$3.67
High$23.20
Today $2.81
RSI (14)
11.1Oversold
03070100
Stocksbrew score
42/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Current price
$2.81
Lowest
$4
Median target
$4.5
Highest
$12
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Price / sales
Strong · Low price-to-sales
0.46x
Debt / equity
Favorable · 0.23 - strong leverage
0.23x
Current ratio
Strong · Good liquidity position
1.88x
⚠ Things to watch
EV / EBITDA
Rich · Earnings can't support price
47.26x
ROIC
Weak · Weak capital efficiency
-3.3%
ROE
Needs attention · Unfavorable
-9.4%
How it stacks up against its peers
TLRY against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $449.27M | - | +15.9% | 42 |
 | $10.30B | 19.6 | +19.7% | 78 |
 | $32.47B | 34.0 | +15.5% | 78 |
 | $3.83B | 11.5 | +13.5% | 78 |
 | $1.18T | 42.7 | +49.6% | 77 |